Would you get a one-time genetic modification such that you'd never have to take a GLP-1 drug for weight loss ever again?

NEW YORK CITY, NY / ACCESS Newswire / July 9, 2025 / Semaglutide is making waves as the powerhouse ingredient in Ozempic and ...

While effective for managing type 2 diabetes and promoting weight loss as a secondary benefit, Ozempic is not suitable for ...

For many, the high cost of the pill means stopping is a matter of 'when,' not 'if.' Endocrinologists reveal the crucial steps ...

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 4.1% in the morning session after the company announced ...

Tom Cowen has been in the fitness industry for more than 20 years and has seen various fads come and go. He fears the current ...

GLP-1 drugs alter taste perceptions, challenging food makers to adapt by enhancing umami flavours, balancing sweetness, and ...

A little over a year after celebrating its 30th anniversary in China with a major production upgrade, Novo Nordisk is back ...

Technology will soon make it possible to develop cheap, widely accessible psychoactive substances that are not harmful in the ...

Stock futures ticked higher on Wednesday (July 9) as investors assessed the latest tariff signals from President Donald Trump ...

The Hims & Hers wellness platform announced Wednesday it will soon offer a generic version of the weight loss drug semaglutide in Canada as Novo Nordisk's patent on its branded version, known as ...